World ADC San Diego
October 8 - October 11
With the next ADC approval in touching distance, the ADC field is on the edge of their seats to hear when the next exciting announcement will be. With new collaborations and important results constantly being shared, it’s safe to say the field is ever-evolving. However, despite the excitement we continue to face roadblocks with off-target toxicity, ensuring a robust supply chain and maximizing the clinical therapeutic window of an ADCs.
Designed with Pfizer, Seattle Genetics, Genentech and ImmunoGen this leading forum will share the latest data, insight and lessons learned providing you with everything you need to advance the next 12 months of your ADC development as well as an unrivaled networking experience.